1. Home
  2. EVOK vs YGMZ Comparison

EVOK vs YGMZ Comparison

Compare EVOK & YGMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • YGMZ
  • Stock Information
  • Founded
  • EVOK 2007
  • YGMZ 2002
  • Country
  • EVOK United States
  • YGMZ China
  • Employees
  • EVOK N/A
  • YGMZ N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • YGMZ Transportation Services
  • Sector
  • EVOK Health Care
  • YGMZ Consumer Discretionary
  • Exchange
  • EVOK Nasdaq
  • YGMZ Nasdaq
  • Market Cap
  • EVOK 7.1M
  • YGMZ 7.0M
  • IPO Year
  • EVOK 2013
  • YGMZ 2020
  • Fundamental
  • Price
  • EVOK $4.75
  • YGMZ $0.66
  • Analyst Decision
  • EVOK
  • YGMZ
  • Analyst Count
  • EVOK 0
  • YGMZ 0
  • Target Price
  • EVOK N/A
  • YGMZ N/A
  • AVG Volume (30 Days)
  • EVOK 10.0K
  • YGMZ 57.6K
  • Earning Date
  • EVOK 03-13-2025
  • YGMZ 01-01-0001
  • Dividend Yield
  • EVOK N/A
  • YGMZ N/A
  • EPS Growth
  • EVOK N/A
  • YGMZ N/A
  • EPS
  • EVOK N/A
  • YGMZ N/A
  • Revenue
  • EVOK $8,617,036.00
  • YGMZ $55,805,416.00
  • Revenue This Year
  • EVOK $97.35
  • YGMZ N/A
  • Revenue Next Year
  • EVOK $99.52
  • YGMZ N/A
  • P/E Ratio
  • EVOK N/A
  • YGMZ N/A
  • Revenue Growth
  • EVOK 100.35
  • YGMZ N/A
  • 52 Week Low
  • EVOK $3.54
  • YGMZ $0.64
  • 52 Week High
  • EVOK $12.32
  • YGMZ $6.24
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 53.11
  • YGMZ 40.85
  • Support Level
  • EVOK $4.68
  • YGMZ $0.64
  • Resistance Level
  • EVOK $5.00
  • YGMZ $0.75
  • Average True Range (ATR)
  • EVOK 0.28
  • YGMZ 0.07
  • MACD
  • EVOK 0.03
  • YGMZ 0.00
  • Stochastic Oscillator
  • EVOK 50.00
  • YGMZ 29.62

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About YGMZ MingZhu Logistics Holdings Limited

MingZhu Logistics Holdings Ltd is a Holding company. Its business activities include trucking services and car owner services. Its segments are the trucking business, car owner services business, and liquor distribution business. It generates the majority of its revenue from the trucking segment.

Share on Social Networks: